Alterity Therapeutics financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$2.32M $1.53M $1.05M $0.51M $0.49M $0.43M $0.22M $0.16M $2.53M $4.64M $8.21M $6.49M $4.90M $3.16M $3.13M $4.95M $0.00M $4.34M $5.12M $3.92M $0.00M
GM % Gross Margin %
-125.72% 0.00% 0.00% 0.00% 0.00% 100.00% -100.50% -155.70% 89.65% 93.64% 94.19% 96.04% 95.06% 92.33% 92.82% 93.49% 0.00% 91.70% 92.88% 92.72% 0.00%
OM Operating Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -209.97% -167.79% -152.91% -163.32% -175.37% -218.12% -262.21% -258.43% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share
$-0.02 $-0.02 $-0.01 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
0m 167.25m 128.14m 150.25m 181.6m 202.54m 233.8m 242.04m 285.74m 340.69m 416.48m 508.71m 533.89m 533.89m 533.89m 536.98m 872.61m 2030.95m 2406.87m 2406.87m 4382.75m
OCF Operating Cash Flow
$-5.35M $-11.42M $-11.65M $-9.20M $-9.39M $-6.99M $-4.71M $-4.56M $-6.85M $-7.95M $-13.54M $-10.87M $-7.42M $-5.87M $-6.25M $-13.95M $-9.43M $-17.33M $-12.34M $-20.04M $0.00M
FCF Free Cash Flow
$-5.48M $-11.47M $-11.71M $0.00M $-9.44M $-7.03M $-4.73M $-4.57M $-6.88M $-7.97M $-12.90M $-10.90M $0.00M $-5.90M $-4.55M $-13.96M $-9.45M $-17.34M $-8.53M $-20.05M $0.00M
FCFS Free Cash Flow Per Share
$-0.07 $-0.09 $-0.09 $-0.07 $-0.05 $-0.03 $-0.02 $-0.02 $-0.02 $-0.02 $-0.03 $-0.02 $-0.01 $-0.01 $-0.01 $-0.02 $-0.01 $-0.01 $-0.01 $-0.01 $0.00